Xu Wang, Ph.D.

Law Clerk

+1 202 408 4058 +1 202 408 4058
xu.wang@finnegan.com xu.wang@finnegan.com

901 New York Avenue, NW
Washington, DC 20001-4413

vCard

Show Xu's work in

Xu Wang, Ph.D., focuses on patent litigation and prosecution, drawing on his background in biomedical engineering, biology, and medical technology. His technical experience spans a range of fields, including medical devices, biotechnology, signal processing, and artificial intelligence (AI).

Xu’s legal experience includes conducting prior art analyses, developing invalidity arguments, and preparing claims charts in patent litigation matters. He has also drafted patent applications and prepared responses to U.S. Patent and Trademark Office (USPTO) actions involving a variety of technologies.

Prior to joining Finnegan, Xu worked as a research engineer at a global medical technology company, contributing to the development of medical imaging systems and AI-enabled Software as a Medical Device (SaMD). His academic research applied engineering and computational approaches to biomedical challenges, spanning neuroscience, medical imaging, AI, and biomedical signal processing. His combined research and industry experience provides a strong foundation for understanding complex inventions and addressing clients’ intellectual property (IP) needs.

Et Cetera

Recipient. Richard C. Lewis, Jr. Memorial Award, 2026.
Coauthor. “Motor imagery training after stroke increases slow-5 oscillations and functional connectivity in the ipsilesional inferior parietal lobule," Neurorehabilitation and Neural Repair, 2020.
Coauthor. “Motor network reorganization after motor imagery training in stroke patients with moderate to severe upper limb impairment,” CNS Neuroscience & Therapeutics, 2023.
Coauthor. “The reorganization of resting-state brain networks associated with motor imagery training in chronic stroke patients,” IEEE Transactions on Neural Systems and Rehabilitation Engineering, 2019.
Coauthor. “Brain–heart interactions underlying traditional Tibetan Buddhist meditation,” Cerebral Cortex, 2020.
Coauthor. “Evidence of mirror therapy for recruitment of ipsilateral motor pathways in stroke recovery: A resting fMRI study,” Neurotherapeutics, 2024.
Coauthor. “BDNF improves axon transportation and rescues visual function in a rodent model of acute elevation of intraocular pressure,” Science China Life Sciences, 2019.
Coauthor. “Long-lasting impairments in rodent oxygen-induced retinopathy measured by retinal vessel density and visual function," Science China Life Sciences, 2020.

Insights

Articles

D. Mass. Patent Litigation Update: September 2026 D. Mass. Patent Litigation Update: September 2026

October 28, 2026

Articles

D. Mass. Patent Litigation Update: March 2026 D. Mass. Patent Litigation Update: March 2026

May 4, 2026

At the PTAB Blog

USPTO Introduces Patent Owner Pre-Order SNQ Briefing in EPR USPTO Introduces Patent Owner Pre-Order SNQ Briefing in EPR

April 3, 2026

Federal Circuit IP Blog

Federal Circuit Affirms Noninfringement Where Expert’s Analysis of Means-Plus-Function Claim Failed to Account for Disclosed Structure Federal Circuit Affirms Noninfringement Where Expert’s Analysis of Means-Plus-Function Claim Failed to Account for Disclosed Structure

March 17, 2026

Federal Circuit IP Blog

Federal Circuit Reverses JMOL and Exclusion of Experts Under Daubert Federal Circuit Reverses JMOL and Exclusion of Experts Under Daubert

March 10, 2026

At the PTAB Blog

Rinsed at the PTAB: Director Pulls the Plug on a Late‑Stage IPR After ITC Validity Findings Rinsed at the PTAB: Director Pulls the Plug on a Late‑Stage IPR After ITC Validity Findings

March 5, 2026

Admissions and Education

Education

George Washington University Law School: J.D., 2026

Shanghai Jiao Tong University: Ph.D., Biomedical Engineering, 2021

Shanghai Jiao Tong University: B.S., Biology, 2015

Languages

Chinese (Mandarin)

Xu's Practices

Global IP Enforcement, Litigation, and Trials: Patent Litigation and Trials
Prosecution and Portfolio Management: Patent Drafting and Prosecution

Xu's Industries

AI, Electronics, and Information Technology: Artificial Intelligence (AI) and Machine Learning (ML); Augmented Reality/Virtual Reality (AR/VR); Electrical and Computer Technology
Life Sciences: Biotechnology; Medical Device and Diagnostics